77 studies found for: Open Studies | "Hypercholesterolemia"
French Observatory of Familial Hypercholesterolemia in Cardiology
Effectiveness of Treatment of Hypercholesterolemia With Rosuvastatin and Ezetimibe
The Rogosin Institute Homozygous Familial Hypercholesterolemia Repository
The Spanish Familial Hypercholesterolaemia Cohort Study
EFFECTS OF CARDICHOL, AN HERBAL DIETARY SUPPLEMENT, IN MODERATE HYPERCHOLESTEROLEMIA
Evaluation of Alirocumab Versus Ezetimibe on Top of Statin in Asia in High Cardiovascular Risk Patients With Hypercholesterolemia
Safety, Tolerability, and Effect of Alirocumab in High Cardiovascular Risk Patients With Severe Hypercholesterolemia Not Adequately Controlled With Conventional Lipid-modifying Therapies (ODYSSEY APPRISE)
A Registration Study for Familial Hypercholesterolemia in Taiwan
MYOCARDIAL SILENT INFARCTIONS AND FIBROSIS IN FAMILIAL HYPERCHOLESTEROLEMIA (CHOLCOEUR)
Russian Familial Hypercholesterolemia Registry
Greek Registry - Familial Hypercholesterolaemia
An 8-Week Dose-Finding Study to Evaluate the Efficacy and Safety of Alirocumab in Children and Adolescents With Heterozygous Familial Hypercholesterolemia
Open Label Study to Evaluate Safety, Tolerability and Efficacy of Evolocumab (AMG 145) in Pediatric Subjects (10 to 17 Years of Age) With Heterozygous Familial Hypercholesterolemia (HeFH) or Homozygous Familial Hypercholesterolemia (HoFH).
Developing and Implementing Familial Hypercholesterolemia Registry
Screening Protocol for a Gene Therapy Trial in Subjects With Homozygous Familial Hypercholesterolemia
|16||Not yet recruiting||
HDL Acute Lipid Optimization in Homozygous Familial Hypercholesterolemia
A Gene Therapy Study for Homozygous Familial Hypercholesterolemia (HoFH)
A Study of ALN-PCSSC in Participants With Homozygous Familial Hypercholesterolemia
Study of MGL-3196 in Patients With Heterozygous Familial Hypercholesterolemia (HeFH)
|20||Not yet recruiting||
Study in Participants ≥12 Years of Age With Homozygous Familial Hypercholesterolemia (hoFH)
† Study has passed its completion date and status has not been verified in more than two years.